(NP (NP (NN Expression)) (PP (IN of) (NP (NP-COOD (NP (NN c-jun)) (, ,) (NP (NN jun) (NN B)) (CC and) (NP (NN jun) (NN D))) (NNS proto-oncogenes))) (PP (IN in) (NP (JJ human) (JJ peripheral-blood) (NNS granulocytes))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (S (NP-SBJ (VBN purified) (JJ human) (JJ peripheral-blood) (NNS granulocytes)) (VP (VBP express) (NP (NP (ADJP (RB constitutively) (JJ significant)) (NNS levels)) (PP (IN of) (NP (NP (NNS proto-oncogenes) (NP-COOD (NP (NN c-jun)) (, ,) (NP (NN jun) (NN B)) (CC and) (NP (NN jun) (NN D)))) (NN mRNA))))))))) (. .))
(S (PP (IN Upon) (NP (NP (JJ functional) (NN activation)) (PP (IN of) (NP (NNS granulocytes))) (PP (IN by) (NP (NP (CD 4) (NN beta-phorbol) (NN 12-myristate) (NN 13-acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-)))))) (, ,) (NP-SBJ-70 (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP-COOD (NP (NN c-jun)) (, ,) (NP (NN jun) (NN B)) (CC and) (NP (NN jun) (NN D))) (NNS transcripts)))) (VP (VBD were) (VP (VBN increased) (NP (-NONE- *-70)))) (. .))
(S (NP-SBJ (DT The) (CD three) (NN jun) (NNS genes)) (VP (VBD showed) (NP (DT a) (JJ similar) (NN time) (NN course)) (PP (IN in) (NP (NP (PRP$ their) (NN induction)) (PP (IN by) (NP (NN PMA))))) (, ,) (S (NP-SBJ-71 (JJ maximal) (NN mRNA) (NNS levels)) (VP (VBG being) (VP (VBN reached) (NP (-NONE- *-71)) (PP-TMP (IN after) (NP (NP (CD 60) (NN min)) (PP (IN of) (NP (NN induction))))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-204 (NP (NN expression)) (PP (IN of) (NP (NP-COOD (NP (NN c-jun)) (, ,) (NP (NN jun) (NN B)) (CC and) (NP (NN jun) (NN D))) (NNS genes)))) (VP (MD might) (VP (VB be) (VP (VBN involved) (NP (-NONE- *-204)) (PP-COOD (PP (IN in) (NP (JJ terminal) (NN granulocyte) (NN differentiation))) (CC or) (PP (IN in) (S (NP-SBJ (-NONE- *)) (VP (VBG regulating) (NP (NN granulocyte) (NN functionality)))))))))))) (. .))
